Analysts Recommended this Stock: Celgene Corporation (CELG)

Marco Green
August 29, 2017

Celgene Corporation (NASDAQ:CELG)'s stock on Monday traded at beginning with a price of $130.65 and when day-trade ended the stock finally moved up 1.52% to reach at $131.65.

The Stock had a 1.38 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.25 and 1.38 respectively. The company reported the earnings of $1.82/Share in the last quarter where the estimated EPS by analysts was $1.78/share.

Celgene Corporation (NASDAQ:CELG) last announced its quarterly earnings results on Thursday, July 27th. It has outperformed by 0.30% the S&P500. The volume of CELG witnessed a shift from 3.27 million shares, based on a 50-day average, to 3.84 million shares. The 8 months bullish chart indicates low risk for the $12.39B company. Westfield Management Com LP reported 1.44 million shares. About 3.59 million shares traded. Total System Services, Inc. It has underperformed by 7.01% the S&P500. Clearbridge Investments LLC now owns 4,601,919 shares of the biopharmaceutical company's stock valued at $572,617,000 after buying an additional 892,392 shares during the period. Sigma Planning invested in 4,091 shares or 0.05% of the stock. Merck & Co Inc (NYSE:MRK) was raised too.

Livforsakringsbolaget Skandia Omsesidigt holds 9.01% of its portfolio in Aspen Insurance Holdings Limited for 32,200 shares. Therefore 84% are positive. Stifel Financial Corp owned about 0.16% of Celgene Corporation worth $151,182,000 at the end of the most recent reporting period. The company was upgraded on Friday, June 16 by Leerink Swann. The firm has "Buy" rating given on Thursday, July 6 by Cantor Fitzgerald. The firm has "Outperform" rating given on Friday, July 28 by BMO Capital Markets. The stock has "Buy" rating by BTIG Research on Thursday, August 4. The firm has "Hold" rating given on Thursday, August 6 by TD Securities. Finemark National Bank & Trust And owns 0.12% invested in Celgene Corporation (NASDAQ:CELG) for 13,096 shares. UBS maintained it with "Neutral" rating and $85 target in Monday, May 2 report.

Investors sentiment decreased to 0.88 in 2016 Q4. Its up 0.15, from 0.98 in 2016Q3. It worsened, as 58 investors sold XOM shares while 851 reduced holdings. Inc. raised its stake in shares of Celgene Corporation by 5.9% in the second quarter. The shares were sold at an average price of $134.52, for a total value of $1,008,900.00. Irving Magee Investment Management, a Pennsylvania-based fund reported 65,257 shares. 149,674 were accumulated by Stralem Communications Inc. (SGMO) stock confirmed the flow of 0.47% with the final price of $10.70. Bbva Compass Retail Bank accumulated 24,294 shares. Markston Intll Ltd Limited Liability Company has 1.05% invested in Celgene Corporation (NASDAQ:CELG) for 95,963 shares. Sunbelt Securities holds 0% or 80 shares. Sunbelt Secs owns 80 shares. Campbell Newman Asset Mgmt holds 0.11% or 5,110 shares.

A number of equities analysts have recently issued reports on CELG shares. The Minnesota-based Sit Invest has invested 0.24% in Celgene Corporation (NASDAQ:CELG). Blackrock owns 7.38M shares. Dsm Cap Prns Lc invested 3.59% of its portfolio in Celgene Corporation (NASDAQ:CELG). Centers Of America accumulated 0.1% or 10,112 shares. Raymond James Svcs Advisors has invested 0.47% in Celgene Corporation (NASDAQ:CELG).

Since February 27, 2017, it had 0 buys, and 4 selling transactions for $4.10 million activity. Swiss National Bank now owns 2,746,896 shares of the biopharmaceutical company's stock worth $341,796,000 after buying an additional 588,000 shares during the last quarter. 5,000 shares were sold by Friedman Michael A, worth $625,000. VESSEY RUPERT sold $575,038 worth of Celgene Corporation (NASDAQ:CELG) on Thursday, June 15.

Celgene Corporation (CELG) has an Analysts' Mean Recommendation of 1.8, according to data compiled by Finviz. The stock has a market cap of $102.85 billion, a price-to-earnings ratio of 40.714 and a beta of 1.89. It has a 9.96 P/E ratio. In addition, it provides general objective reloadable (GPR) prepaid and payroll cards, and alternative financial service solutions to the underbanked and other consumers. One analyst has rated the stock with a sell rating, six have given a hold rating and twenty-three have assigned a buy rating to the company's stock. Therefore 64% are positive. Pdts Prtnrs Ltd Liability Corp invested 0.36% of its portfolio in Celgene Corporation (NASDAQ:CELG).

The stock is now showing YTD performance of 13.74 Percent. The company was maintained on Thursday, June 1 by Mizuho. The Market Capitalization of the company stands at 103.29 Billion. Oppenheimer maintained the shares of CELG in report on Wednesday, June 14 with "Buy" rating. The rating was maintained by HSBC with "Hold" on Wednesday, March 8. As per Monday, August 28, the company rating was maintained by Cantor Fitzgerald. The rating was downgraded by Citigroup to "Neutral" on Friday, February 3. The stock has "Neutral" rating by Mizuho on Friday, September 30. BTIG Research maintained the shares of MBI in report on Friday, May 26 with "Buy" rating. The firm has "Outperform" rating by Wells Fargo given on Friday, April 21. 118.59 million shares or 2.71% more from 115.46 million shares in 2016Q3 were reported. $372,434 worth of stock was sold by WOODS M TROY on Wednesday, May 3.

Investors sentiment increased to 1.34 in Q4 2016. Its down 0.44, from 1.15 in 2016Q3. It is positive, as 57 investors sold CELG shares while 470 reduced holdings. 0 funds opened positions while 0 raised stakes. Cornerstone stated it has 1,630 shares. (NYSE:MBI). Hightower Advsrs Ltd Liability Corporation holds 0% or 27,827 shares. (NYSE:MBI) or 25,861 shares. Shanda Asset Hldgs Limited holds 21,785 shares or 0.35% of its portfolio. Highbridge Cap Limited Com reported 16,651 shares. The stock increased 1.52% or $1.97 during the last trading session, reaching $131.65. Schwab Charles reported 670,516 shares stake.

Other reports by Click Lancashire

Discuss This Article